Reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering: a role for fenofibrate. Introduction.

The American journal of cardiology

Volumn 102, Issue 12 A, 2008, Pages

  Sacks, Frank M ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; FENOFIBRATE;

CARDIOVASCULAR DISEASE; EDITORIAL; HUMAN; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; RISK ASSESSMENT; RISK REDUCTION; UNITED STATES;

CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FENOFIBRATE; HUMANS; HYPOLIPIDEMIC AGENTS; METABOLIC SYNDROME X; OBESITY; RISK ASSESSMENT; RISK REDUCTION BEHAVIOR; UNITED STATES;

EID: 79959349337     PISSN: None     EISSN: 18791913     Source Type: Journal    
DOI: None     Document Type: Editorial

References (0)